scholarly journals Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Yi-Chih Chen ◽  
Chih-Ken Chen ◽  
Liang-Jen Wang
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Mood Disorder ◽  
Quetiapine Fumarate

Interpersonal subtypes and change of interpersonal problems in the treatment of patients with generalized anxiety disorder: A pilot study.

Psychotherapy ◽  
2011 ◽  
Vol 48 (3) ◽  
pp. 304-310 ◽  
Author(s):  
Simone Salzer ◽  
Aaron L. Pincus ◽  
Christel Winkelbach ◽  
Falk Leichsenring ◽  
Eric Leibing
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Generalized Anxiety Disorder ◽  
Interpersonal Problems ◽  
Generalized Anxiety

A Pilot Study of Anterior Cingulate Cortex Neurochemistry in Adolescents with Generalized Anxiety Disorder

2013 ◽  
Vol 67 (4) ◽  
pp. 224-229 ◽  
Author(s):  
Jeffrey R. Strawn ◽  
Wen-Jang Chu ◽  
Rachel M. Whitsel ◽  
Wade A. Weber ◽  
Matthew M. Norris ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Anterior Cingulate Cortex ◽  
Generalized Anxiety Disorder ◽  
Cingulate Cortex ◽  
Anterior Cingulate ◽  
Generalized Anxiety

A Pilot Study of Switching Electroconvulsive Therapy for Patients With Treatment Resistant Schizophrenia or Mood Disorder

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Xiao Wei Tan ◽  
Li Keat Oon ◽  
Yun Ying Tammy Tsang ◽  
Hatta Santoso Ong ◽  
Phern Chern Tor
Keyword(s):  
Pilot Study ◽  
Mood Disorder ◽  
Electroconvulsive Therapy ◽  
Treatment Resistant

scholarly journals The Effects of Approach–Avoidance Modification on Social Anxiety Disorder: A Pilot Study

2013 ◽  
Vol 38 (2) ◽  
pp. 226-238 ◽  
Author(s):  
Anu Asnaani ◽  
Mike Rinck ◽  
Eni Becker ◽  
Stefan G. Hofmann
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Approach Avoidance

Citalopram for Social Anxiety Disorder: An Open-label Pilot Study in Refractory and Nonrefractory Patients

CNS Spectrums ◽  
2002 ◽  
Vol 7 (9) ◽  
pp. 655-657 ◽  
Author(s):  
Naomi M. Simon ◽  
Nicole B. Korbly ◽  
John J. Worthington ◽  
Gustavo Kinrys ◽  
Mark H. Pollack
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Prior Treatment ◽  
Treatment Intervention ◽  
Treatment Trial ◽  
Open Label ◽  
Systematic Data ◽  
Open Label Trial

ABSTRACTThere is limited systematic data assessing alternate pharmacotherapy of social anxiety disorder in patients failing to tolerate or fully respond to initial treatment; no data specifically address the efficacy of citalopram in this scenario. We present a prospective open-label trial of citalopram in 10 patients with generalized social anxiety disorder, 6 of 10 of whom had not responded to or not tolerated a prior treatment intervention for the disorder. Citalopram, at a mean dose of 55 mg (SD+12.7 mg) was well tolerated, and patients improved significantly on all outcome measures. Results of this study suggest that citalopram may be a safe and effective treatment for generalized social anxiety disorder, including patients who have failed to tolerate or respond to a prior treatment trial.

Sign in / Sign up

Export Citation Format

Share Document